GSK in Collaboration with Sembcorp to Reach 100 percent Renewable Electricity
Manufacturing operations in Singapore will move from 3 percent to 100 percent renewable electricity, generated directly on-site and procured through renewable energy certificates from solar projects an important step towards GSK’s global target of 100 percent.
June 29, 2024. By News Bureau
GSK has announced it has signed a 10-year energy deal with Sembcorp, covering the electricity demand for all three of GSK’s global manufacturing sites in Singapore from January 1, 2025.
This agreement would facilitate the supply of renewable energy certificates for up to 87,600 MWh of electricity annually, equivalent to approximately 36,500 MT of CO22, increasing GSK’s global purchased renewable electricity usage by 9 percent.
GSK’s manufacturing facilities in Singapore are critical for the production of innovative medicines and vaccines for HIV, oncology and infectious diseases. This deal is part of GSK’s continued investment and commitment to Singapore, where it has been present since 1959 and today employs over 1,500 people. It has invested more than USD 2.5 billion in Singapore to date.
Regis Simard, President, Global Supply Chain, GSK said, “I’m proud that we’ve been able to sign this deal to transition our manufacturing sites in Singapore to renewable electricity from 2025. We are working to decarbonise our manufacturing facilities globally through purchasing renewable electricity as well as investing in on-site renewable electricity generation.”
Vickrem Vijayan, Head of Energy Commercial, Singapore, Sembcorp said, “As a leading renewable energy player in Asia, Sembcorp is well-equipped to support its customers to decarbonise through its global renewable energy portfolio and suite of carbon management solutions.”
Manufacturing operations in Singapore will move from 3 percent to 100 percent renewable electricity, generated directly on-site and procured through renewable energy certificates from solar projects an important step towards GSK’s global target of 100 percent. Transitioning to renewable energy will improve air quality, it also has important benefits for respiratory and human health. At a global level, GSK is committed to an 80 percent reduction in greenhouse gas emissions across all scopes by 2030 and a 90 percent reduction by 2045, from a 2020 baseline.
This agreement would facilitate the supply of renewable energy certificates for up to 87,600 MWh of electricity annually, equivalent to approximately 36,500 MT of CO22, increasing GSK’s global purchased renewable electricity usage by 9 percent.
GSK’s manufacturing facilities in Singapore are critical for the production of innovative medicines and vaccines for HIV, oncology and infectious diseases. This deal is part of GSK’s continued investment and commitment to Singapore, where it has been present since 1959 and today employs over 1,500 people. It has invested more than USD 2.5 billion in Singapore to date.
Regis Simard, President, Global Supply Chain, GSK said, “I’m proud that we’ve been able to sign this deal to transition our manufacturing sites in Singapore to renewable electricity from 2025. We are working to decarbonise our manufacturing facilities globally through purchasing renewable electricity as well as investing in on-site renewable electricity generation.”
Vickrem Vijayan, Head of Energy Commercial, Singapore, Sembcorp said, “As a leading renewable energy player in Asia, Sembcorp is well-equipped to support its customers to decarbonise through its global renewable energy portfolio and suite of carbon management solutions.”
Manufacturing operations in Singapore will move from 3 percent to 100 percent renewable electricity, generated directly on-site and procured through renewable energy certificates from solar projects an important step towards GSK’s global target of 100 percent. Transitioning to renewable energy will improve air quality, it also has important benefits for respiratory and human health. At a global level, GSK is committed to an 80 percent reduction in greenhouse gas emissions across all scopes by 2030 and a 90 percent reduction by 2045, from a 2020 baseline.
If you want to cooperate with us and would like to reuse some of our content,
please contact: contact@energetica-india.net.
please contact: contact@energetica-india.net.